ZA954074B - Acylated aminoalkanimidazoles and -triazoles - Google Patents
Acylated aminoalkanimidazoles and -triazolesInfo
- Publication number
- ZA954074B ZA954074B ZA954074A ZA954074A ZA954074B ZA 954074 B ZA954074 B ZA 954074B ZA 954074 A ZA954074 A ZA 954074A ZA 954074 A ZA954074 A ZA 954074A ZA 954074 B ZA954074 B ZA 954074B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazoles
- compounds
- aminoalkanimidazoles
- acylated
- acylated aminoalkanimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Lubricants (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9409882A GB9409882D0 (en) | 1994-05-18 | 1994-05-18 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA954074B true ZA954074B (en) | 1996-11-18 |
Family
ID=10755289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA954074A ZA954074B (en) | 1994-05-18 | 1995-05-18 | Acylated aminoalkanimidazoles and -triazoles |
Country Status (30)
Country | Link |
---|---|
US (1) | US5622982A (xx) |
EP (1) | EP0683156B1 (xx) |
JP (1) | JP2912566B2 (xx) |
KR (1) | KR100371465B1 (xx) |
CN (1) | CN1060163C (xx) |
AT (1) | ATE164576T1 (xx) |
AU (1) | AU696880B2 (xx) |
BR (1) | BR9502062A (xx) |
CA (1) | CA2149459C (xx) |
CO (1) | CO4290423A1 (xx) |
CZ (1) | CZ285385B6 (xx) |
DE (1) | DE69501915T2 (xx) |
DK (1) | DK0683156T3 (xx) |
ES (1) | ES2114289T3 (xx) |
FI (1) | FI112364B (xx) |
GB (1) | GB9409882D0 (xx) |
GR (1) | GR3026505T3 (xx) |
HK (1) | HK1008743A1 (xx) |
HU (1) | HUT72063A (xx) |
IL (1) | IL113743A (xx) |
MY (1) | MY135559A (xx) |
NO (1) | NO304738B1 (xx) |
NZ (1) | NZ272129A (xx) |
PE (1) | PE14896A1 (xx) |
PH (1) | PH31510A (xx) |
RU (1) | RU2152933C2 (xx) |
SI (1) | SI0683156T1 (xx) |
SK (1) | SK280326B6 (xx) |
TW (1) | TW351718B (xx) |
ZA (1) | ZA954074B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE171945T1 (de) * | 1993-07-15 | 1998-10-15 | Pfizer | Benzyloxychinuclidine als substanz p antagonisten |
AU5347696A (en) * | 1995-11-20 | 1997-06-11 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
WO1998053806A1 (fr) * | 1997-05-26 | 1998-12-03 | New Vision Co., Ltd. | Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k |
US6034251A (en) * | 1997-11-07 | 2000-03-07 | Schering Corporation | Phenyl-alkyl-imidazoles |
TW575562B (en) * | 1998-02-19 | 2004-02-11 | Agrevo Uk Ltd | Fungicides |
IL129596A (en) * | 1998-05-08 | 2003-10-31 | Dow Agrosciences Llc | Preparation of 2-substituted pyridines |
GB0029524D0 (en) * | 2000-12-04 | 2001-01-17 | Univ Sheffield | Disease treatment |
GB0128415D0 (en) * | 2001-11-27 | 2002-01-16 | Univ Sheffield | Medicaments |
US7429604B2 (en) * | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
US20060078494A1 (en) * | 2004-09-24 | 2006-04-13 | Sapphire Therapeutics, Inc. | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
WO2006032299A1 (en) * | 2004-09-24 | 2006-03-30 | Susanna Miettinen | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
CN104530038A (zh) * | 2014-12-10 | 2015-04-22 | 沈阳药科大学 | 酰胺咪唑类衍生物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2041771C3 (de) * | 1970-08-22 | 1979-07-26 | Bayer Ag, 5090 Leverkusen | derivate |
US4191767A (en) * | 1977-01-07 | 1980-03-04 | Westwood Pharmaceuticals, Inc. | Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines |
CH655103A5 (de) * | 1983-03-11 | 1986-03-27 | Sandoz Ag | Azolderivate, verfahren zu ihrer herstellung und ihre verwendung. |
CH677925A5 (xx) * | 1986-12-03 | 1991-07-15 | Sandoz Ag |
-
1994
- 1994-05-18 GB GB9409882A patent/GB9409882D0/en active Pending
-
1995
- 1995-05-16 EP EP95810325A patent/EP0683156B1/en not_active Expired - Lifetime
- 1995-05-16 PE PE1995268750A patent/PE14896A1/es not_active Application Discontinuation
- 1995-05-16 IL IL11374395A patent/IL113743A/xx not_active IP Right Cessation
- 1995-05-16 NO NO951944A patent/NO304738B1/no not_active IP Right Cessation
- 1995-05-16 AU AU20089/95A patent/AU696880B2/en not_active Ceased
- 1995-05-16 ES ES95810325T patent/ES2114289T3/es not_active Expired - Lifetime
- 1995-05-16 NZ NZ272129A patent/NZ272129A/en not_active IP Right Cessation
- 1995-05-16 DE DE69501915T patent/DE69501915T2/de not_active Expired - Lifetime
- 1995-05-16 SI SI9530063T patent/SI0683156T1/xx not_active IP Right Cessation
- 1995-05-16 CA CA002149459A patent/CA2149459C/en not_active Expired - Fee Related
- 1995-05-16 CZ CZ951265A patent/CZ285385B6/cs not_active IP Right Cessation
- 1995-05-16 DK DK95810325T patent/DK0683156T3/da active
- 1995-05-16 AT AT95810325T patent/ATE164576T1/de not_active IP Right Cessation
- 1995-05-16 SK SK635-95A patent/SK280326B6/sk not_active IP Right Cessation
- 1995-05-16 US US08/442,053 patent/US5622982A/en not_active Expired - Lifetime
- 1995-05-16 FI FI952383A patent/FI112364B/fi active
- 1995-05-16 MY MYPI95001281A patent/MY135559A/en unknown
- 1995-05-16 RU RU95107652/04A patent/RU2152933C2/ru not_active IP Right Cessation
- 1995-05-17 JP JP7118345A patent/JP2912566B2/ja not_active Expired - Fee Related
- 1995-05-17 PH PH50532A patent/PH31510A/en unknown
- 1995-05-17 KR KR1019950012172A patent/KR100371465B1/ko not_active IP Right Cessation
- 1995-05-17 CN CN95106034A patent/CN1060163C/zh not_active Expired - Fee Related
- 1995-05-17 HU HU9501451A patent/HUT72063A/hu not_active Application Discontinuation
- 1995-05-17 CO CO95021039A patent/CO4290423A1/es unknown
- 1995-05-17 BR BR9502062A patent/BR9502062A/pt not_active IP Right Cessation
- 1995-05-18 ZA ZA954074A patent/ZA954074B/xx unknown
- 1995-05-19 TW TW084105010A patent/TW351718B/zh not_active IP Right Cessation
-
1998
- 1998-04-03 GR GR980400688T patent/GR3026505T3/el unknown
- 1998-07-20 HK HK98109296A patent/HK1008743A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138402A0 (en) | Heterocyclically substituted amides used as calpain inhibitors | |
DE69908819D1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
PL304649A1 (en) | Novel derivatives of taxane and pharmaceutical agents | |
ZA954074B (en) | Acylated aminoalkanimidazoles and -triazoles | |
CA2214131A1 (en) | Trisubstituted phenyl derivatives | |
DE69008142D1 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
DE69229339D1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
PT626385E (pt) | Derivados do tetra-hidropirano | |
IL105607A0 (en) | Heteroatoms-containing tricyclic compounds,their preparation and pharmaceutical compositions containing them | |
NO923983D0 (no) | Bisfenyletanderivater, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse | |
MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
EP0551844A3 (xx) | ||
IL88539A0 (en) | Azole compounds,their preparation and their use as fungicides | |
MY133139A (en) | N-substituted azabicycloheptane derivatives, their preparation and use |